Stockholders’ Equity (Tables)

12 Months Ended

Mar. 29, 2025

Equity [Abstract]

Schedule of Stock Options Outstanding

A summary of the status of the Company’s stock options outstanding as of March 29, 2025 and changes during the year then ended is presented below. All cashless exercises of options are handled through an independent broker.

	Number Of Common Stock Options			Weighted Average Exercise Price Per Share		Weighted Average Contractual Life (Years)		Intrinsic Value
Outstanding, March 30, 2024		505,892		$	171.38		3.6	$	50.1
Awarded		44,334			297.81
Exercised		(223,693	)		156.25
Forfeitures		(11,839	)		189.67
Expirations		(675	)		163.35
Outstanding, March 29, 2025		314,019		$	199.24		3.7	$	39.7
Exercisable, March 29, 2025		123,255		$	168.15		2.5	$	19.4

Schedule of Grant using the Black-Scholes Option Pricing Model

The fair value for the Company’s options was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions, which are updated to reflect current expectations of the dividend yield, expected life, risk-free interest rate and using historical volatility to project expected volatility:

	Fiscal Year Ended
	March 29, 2025			March 30, 2024			April 1, 2023
Dividend yield		0.00	%		0.00	%		0.00	%
Expected weighted-average life (yrs.)		5.0			5.0			5.0
Risk-free interest rate		3.87	%		4.20	%		3.05	%
Expected volatility		45.95	%		46.71	%		45.57	%

Schedule of Restricted Stock Outstanding

A summary of the status of the Company’s restricted stock outstanding as of March 29, 2025 and the changes during the year then ended is presented below.

	Number Of Restricted Stock Shares			Weighted-Average Grant Date Fair Value
Non-vested, March 30, 2024		173,445		$	199.09
Granted		46,298			294.66
Vested		(81,730	)		196.77
Forfeitures		(5,201	)		190.12
Non-vested, March 29, 2025		132,812		$	234.18

Schedule of Liability Classified Awards Outstanding

A summary of the status of the Company’s liability classified awards outstanding as of March 29, 2025 and the changes during the year then ended is presented below.

	Intrinsic Value
Outstanding, March 30, 2024	$	11.7
Awarded		4.7
Vested		(5.8	)
Cancelled		—
Change in fair value		2.7
Outstanding, March 29, 2025	$	13.3
Estimated liability as of  March 29, 2025	$	8.4